Replies to post #211926 on Innovation Pharmaceuticals Inc (IPIX)

[KMBJN]

Kevetrin and IPIX remain under the radar for now.

Kevetrin MOA studies and publications should help that, along with a big partner signing on to help develop it, and/or clinical results.

The other p53 mutant activating drugs show they reactivate mutant p53 by knocking it out and seeing that the drugs don't stop cancer quite as well in the dish.

This statement is also important:

"It remains to be shown however, whether any mutant p53 reactivating compound has ef?cacy for the treatment of human cancer."

[cabel]

You criticize Leo continually but you stick around, probably still invested,... funny way to invest!